What AI says about Foundayo
Part of Eli Lilly and Company
Since Jul 5Updated Oct 28, 2026Based on 6,773 AI responses
Reviewed by Dimitry Apollonsky
Eli Lilly and Company<1%
Products
- Zepbound4%
- Tirzepatide<1%
- FoundayoThis page<1%
- LillyDirect<1%
- Mounjaro<1%
- Lilly TuneLab<1%
Mentioned in
<1%
of AI answers about Foundayo and its rivals
Where Foundayo ranks in AI
MarketRank · Mentioned in
Topics where AI mentions Foundayo
TopicMentioned in · on this topicRank
- AI picks mostMentioned in
- which weight loss pills actually work?on this questionAI picks Qsymia and 2 more about as often50%
Excerpts where Foundayo appeared in the AI's answer
Google AI ModeSep 17, 2026, Google AI Mode Foundayo (Orforglipron): Efficacy : One of the newest and most potent weight-loss tablets available.
Google AI ModeSep 13, 2026, Google AI Mode Foundayo Go to product viewer dialog for this item. (Orforglipron): A newer, once-daily non-peptide GLP-1 receptor agonist pill that targets hunger signals to help patients feel full much sooner.
- which appetite suppressant works best for me?on this questionAI picks Wegovy and 2 more about as often2%
- As a busy professional, where can I get a legitimate GLP-1 prescription through telehealth?on this questionAI picks Zepbound and 1 more about as often2%
Foundayo in AI’s own words
How prominently AI mentions Foundayo
Position in answers
- Named first5%
- 2nd or 3rd77%
- Later18%
Each engine’s share of its own answers across Foundayo’s markets
- ChatGPT<1%
- Google AI Mode1%
Sources AI cites
foundayo.lilly.com 0%Other sites 100%
The page AI cites most for Foundayo
Check it mentions Foundayo and gets the details right.
